Patients should increase home glucose monitoring frequency during the transition period and work with their healthcare provider to adjust or initiate alternative diabetes medications as needed
Keep it comfortable with DISONCARE.
The semaglutide constipation treatment guide and GLP-1 constipation relief article both cover this extensively
Search (SciFinder database) 910463-68-2 Sequence search (Lens database) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Sequence search (NCBI Blast database) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Sequence search (SureChEMBL) HXEGTFTSDVSSYLEGQAAKEFIAWLVRGRG Mounjaro and Zepbound (tirzepatide) Keyword search ((+TIRZEPATID+ OR MOUNJARO+ OR ZEPBOUND+ OR LY3298176+ OR L__Y3298176 OR (LY 2W 3298176) OR (2023788__19__2) OR (2023788 2W 19 2W 2) OR TWINCRETIN OR GIP/GLP-1 RA OR GIP__GLP___1___RA OR (GIP 2W GLP 2W 1 2W RA) OR (DUAL__GIP__ GLP__1__AGONIST?) OR (DUAL 2W GIP 2W GLP 2W 1 2W AGONIST?) OR +YXEGTFTSDYSIXLDKIAQKAFVQWLIAGGPSSGAPPPS+) Broad drug category Keyword search (((GLUCAGON__LIKE__PEPTIDE__1) OR (GLUCAGON 3W LIKE 3W PEPTIDE 3W 1) OR (GLP__1) OR (GLP 3W 1) OR GLP__1RA OR (GLP 2W 1RA) OR GLP__1R+ OR GLP1 OR (GLUCOSE__DEPENDENT__INSULINOTROPIC__POLYPEPTIDE+) OR (GLUCOSE 2W DEPENDENT 2W INSULINOTROPIC 2W POLYPEPTIDE+) OR (GASTRIC__INHIBITORY__POLYPEPTIDE+) OR (GASTRIC 2W INHIBITORY 2W POLYPEPTIDE+) OR GIP OR GIPR OR GIP_R OR GIP_R
Side Effects and Safety Profile Common side effects are mostly gastrointestinal and dose-dependent, including nausea, vomiting, diarrhea, constipation, and decreased appetite
Obesity: definition, comorbidities, causes, and burden
.webp)
